Biedrzycki, P. 2007. Antiviral distribution during an influenza pandemic—LPHA planning considerations. Presentation at Meeting One of the Institute of Medicine Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic. Washington, DC.

Call, S. A., M. A. Vollenweider, C. A. Hornung, D. L. Simel, and W. P. McKinney. 2005. Does this patient have influenza? Journal of the American Medical Association 293:987-997.

Carpenter, M., J. Hodge, and R. Pepe. 2008. Deploying and using volunteer health practitioners in response to emergencies: Proposed uniform state legislation provides liability protections and workers’ compensation coverage. American Journal of Disaster Medicine 3(1):17-24.

CDC (Centers for Disease Control and Prevention). 2006a. CDC Health Alert: CDC recommends against the use of amantadine and rimantadine for the treatment or prophylaxis of influenza in the United States during the 2005–2006 influenza season. http://www.cdc.gov/flu/han011406.htm (accessed April 9, 2008).

CDC. 2006b. Pandemic influenza guidance supplement to the 2006 public health emergency preparedness cooperative agreement phase II (July 10, 2006). http://www.bt.cdc.gov/planning/coopagreement/pdf/phase2-panflu-guidance.pdf (accessed April 9, 2008).

CDC. 2006c. Rapid diagnostic testing for influenza: Information for clinical laboratory directors. http://www.cdc.gov/flu/professionals/diagnosis/pdf/flu-rapid-test-lab-director.pdf (accessed April 9, 2008).

CDC. 2006d, April 8. Public health emergency preparedness cooperative agreement supplement. Washington, DC: DHHS.

CDC. 2007a. Interim pre-pandemic planning guidance: Community strategy for pandemic influenza mitigation in the United States—early, targeted, layered use of nonpharmaceutical interventions. http://www.pandemicflu.gov/plan/community/community-mitigation.pdf (accessed April 9, 2008).

CDC. 2007b. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) 56(rr06):1-54. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5606a1.htm (accessed March 31, 2008).

CDC. 2008. Pandemic influenza funding announcement for competitive proposals (activities) (DCD-RFA-TP08-802). http://www.bt.cdc.gov/planning/coopagreement/pdf/panflu-funding-opportunity-tp08-802.pdf (accessed April 4, 2008).

Denver Health. 2007. Adapting community call centers for crisis support: A model for home-based care and monitoring. Denver, CO: Denver Health.

DHHS (Department of Health and Human Services). 2005. DHHS pandemic influenza plan. Washington, DC: DHHS. http://www.hhs.gov/pandemicflu/plan/pdf/HHSPandemicInfluenzaPlan.pdf (accessed April 29, 2008).

DHHS. 2007a. Draft proposed guidance on antiviral drug use strategies during an influenza pandemic. Washington, DC: DHHS. http://www.asisonline.org/newsroom/crisisResponse/Antiviral_overview_11-6-07.doc (accessed April 29, 2008).

DHHS. 2007b. Revised summary of proposed guidance on antiviral drug use strategies for an influenza pandemic. DHHS. Washington, DC: DHHS.

DHHS. 2007c. Pandemic planning update IV. Washington, DC: DHHS. http://www.pandemicflu.gov/plan/panflureport4.pdf (accessed April 9, 2008).

DoD (Department of Defense). 2007. The DoD/FDA shelf-life extension program to extend the shelf life of critical stockpiles of medical material for the federal government. Washington, DC: DoD.

Duffy, E. 2007. Letter to Hoffman la-Roche, Inc., December 3, 2007.

EMEA (European Medicines Agency). 2005. Summary report: Review on influenza antiviral medicinal products for potential use during pandemic. London, UK: EMEA.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement